Dilaudid and Xywav drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Xywav (calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate). Common drug interactions include muscle spasms among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Xywav. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Xywav?

Xywav has active ingredients of calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate. eHealthMe is studying from 7,134 Xywav users. Check the latest studies of Xywav.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

29 people who take Dilaudid and Xywav together, and have interactions are studied.

Dilaudid and Xywav drug interactions.

What are the common drug interactions of Dilaudid and Xywav, by gender? *:

female:

  1. Muscle spasms (muscle contraction)
  2. Knee arthroplasty
  3. Nausea (feeling of having an urge to vomit)
  4. Tendon rupture (tear of tendon)
  5. Fall
  6. Head injury
  7. Subdural haematoma (blood collects between the skull and the surface of the brain)
  8. Anxiety
  9. Cellulitis (infection under the skin)
  10. Hospitalisation

male:

  1. Hospitalisation
  2. Migraine (headache)
  3. Tinnitus (a ringing in the ears)
  4. Arrhythmia (irregular heartbeat)
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Chest pain
  7. Diabetic nephropathy (diabetic kidney disease)
  8. Drug hypersensitivity
  9. Foot fracture
  10. Hyperkalaemia (damage to or disease of the kidney)

What are the common drug interactions of Dilaudid and Xywav, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hospitalisation
  2. Agitation (state of anxiety or nervous excitement)
  3. Craniocerebral injury (injury to cranium and brain)
  4. Hepatic enzyme increased
  5. Migraine (headache)
  6. Overdose
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Snoring
  9. Suicidal ideation
  10. Suicide attempt

40-49:

  1. Cellulitis (infection under the skin)
  2. Retching (strong involuntary effort to vomit)
  3. Rotator cuff repair
  4. Sleep disorder
  5. Cardiac failure congestive
  6. Cardiomyopathy (weakening of the heart muscle)
  7. Menopause (end of monthly cycles in women)
  8. Post procedural complication

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Anxiety
  3. Breast cancer
  4. Muscle spasms (muscle contraction)
  5. Panic attack
  6. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  7. Chronic kidney disease
  8. Dizziness
  9. Head discomfort
  10. Hyperhidrosis (abnormally increased sweating)

60+:

  1. Knee arthroplasty
  2. Tendon rupture (tear of tendon)
  3. Brain injury
  4. Diplopia (double vision)
  5. Eye infection
  6. Hypotension (abnormally low blood pressure)
  7. Uterine disorder
  8. Accident
  9. Adrenocortical carcinoma (adrenal cortex cancer)
  10. Breakthrough pain

What are the existing conditions these people have? *

  1. Drowsiness: 27 people, 93.10%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 22 people, 75.86%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 19 people, 65.52%
  4. High Blood Pressure: 2 people, 6.90%
  5. Headache (pain in head): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and Xywav?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilaudid and Xywav:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xywav:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xywav and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride and calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate (the active ingredients of Dilaudid and Xywav, respectively), and Dilaudid and Xywav (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: